Henan Lingrui Pharmaceutical Co., Ltd.

XSSC:600285 Stock Report

Market Cap: CN¥12.1b

Henan Lingrui Pharmaceutical Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Wei Xiong

Chief executive officer

CN¥1.8m

Total compensation

CEO salary percentagen/a
CEO tenure1.5yrs
CEO ownership0.6%
Management average tenureno data
Board average tenureno data

Recent management updates

Recent updates


CEO

Wei Xiong (39 yo)

1.5yrs

Tenure

CN¥1,804,900

Compensation

Mr. Wei Xiong serves as General Manager and Chairman at Henan Lingrui Pharmaceutical Co. Ltd. since May 18, 2023 and served as its Managing Director.